T his 1-day-old baby boy was transferred for evaluation of a liver mass. He was the 2,250-g product of a 38-week gestation to a 25-year-old gravida 1 para 1 (G1P1) woman. Following an uneventful pregnancy, labor and delivery, the baby's abdomen was distended at 25 hours of life. X-rays at the outside hospital revealed an enlarged heart and liver. Ultrasound demonstrated a possible arteriovenous malformation (AVM) prompting transfer. The family history was unremarkable.
A 1-day-old Boy with a Liver Mass
Robert Listernick, MD T his 1-day-old baby boy was transferred for evaluation of a liver mass. He was the 2,250-g product of a 38-week gestation to a 25-year-old gravida 1 para 1 (G1P1) woman. Following an uneventful pregnancy, labor and delivery, the baby's abdomen was distended at 25 hours of life. X-rays at the outside hospital revealed an enlarged heart and liver. Ultrasound demonstrated a possible arteriovenous malformation (AVM) prompting transfer. The family history was unremarkable.
On exam, the baby was intubated and on the ventilator. Weight and length were below the 5th percentile for age, and head circumference was in the 20th percentile. He was normocephalic. There were no dysmorphic features. There were several 1-2 mm tan nodules noted on both irides. There were two natal teeth. Lungs were clear. S1 and S2 were normal. There was a II/VI holosystolic murmur heard best at the left upper sternal border with radiation to the back. The abdomen was distended. The liver was palpable down to the level of the umbilicus and across the midline beneath the left subcostal margin. There was no palpable spleen. Genitalia and extremities were normal. There were no cutaneous lesions.
Echocardiography revealed a patent foramen ovale with bidirectional shunting. There were moderately dilated right heart chambers with a large patent ductus arteriosus. There was moderately depressed right ventricular systolic function and signifi cantly elevated main pulmonary artery pressures.
Robert Listernick, MD, moderator: Can we see the radiology studies?
Ellen Benya, MD, pediatric radiologist: The initial babygram showed marked cardiomegaly and suggestion of hepatomegaly.
Wayne Franklin, MD, pediatric cardiologist:
The heart is massively enlarged, and the pulmonary vasculature looks normal or somewhat decreased. If this patient had low oxygen saturations, this would be a classic X-ray of Ebstein's anomaly, an abnormality resulting from a lack of delamination of the septal and posterior leafl ets of the tricuspid valve, which leads to marked enlargement of the right atrium and relative hypoplasia of the functional right ventricle. Other potential cardiac lesions with this X-ray before we know the results of the echocardiogram include left-sided obstructive lesions, such as left hypoplastic heart or critical coarctation of the aorta or tetralogy of Fallot with absent pulmonary valve leafl ets. Ventricular septal defects wouldn't present at this early an age.
Dr. Benya: Because we knew that the heart was structurally normal despite the poor function, we decided to perform hepatic ultrasonography looking for vascular lesions that might lead to congestive heart failure. There was a large heterogeneously echogenic mass on the right side of the liver, with several smaller lesions on the left. The large lesion was extremely vascular, whereas the lesions in the Children's Memorial Hospital, Chicago, IL. doi: 10.3928/00904481-20100521-03 Following an uneventful pregnancy, labor and delivery, the baby's abdomen was distended at 25 hours of life.
3906FirmRounds.indd 332 3906FirmRounds.indd 332 6/4/2010 1:27:00 PM 6/4/2010 1:27:00 PM left lobe were less so. The differential diagnosis based on these fi ndings includes hemangioendotheliomas, which can be multifocal, large AVMs, and congenital hemangiomas.
Dr. Listernick: Let's talk about large vascular lesions of the newborn.
Anthony Mancini, MD, pediatric dermatologist: When I fi rst heard about the patient, I tried to tie together the simultaneous presence of natal teeth and vascular lesions. I couldn't fi nd any syndrome that fi t. Natal teeth can be seen in infants who have histiocytosis, but that didn't fi t the clinical picture.
Ellen mentioned the three possible vascular lesions. Distinguishing among them may be very diffi cult, even in the hands of an experienced radiologist. Tissue biopsy ultimately may be necessary. Hemangiomas may be present in the liver at birth and may even be seen on prenatal ultrasounds. The lack of cutaneous hemangiomas makes this diagnosis less likely. There are three possible patterns of liver hemangiomas. The fi rst is multifocal small lesions, such as we see in babies with multifocal cutaneous hemangiomas; these have a very good prognosis. They don't cause heart failure.
Dr. Listernick: How do these infants present? Dr. Mancini: They're usually an asymptomatic fi nding on ultrasonography of a baby who has multiple cutaneous hemangiomas without hepatomegaly. The two other patterns of neonatal hemangiomas include a large hemangioma of the liver causing heart failure and massive effacement of the liver by an hemangioma, which has a high mortality rate. In the latter case, hypothyroidism may be seen because of degradation of thyroxine by the hemangioma.
Dr. Listernick: What about the other two lesions?
Dr. Mancini: AVM is not a proliferative neoplasm but may be hard to distinguish from a hemangioma. Hemangioendotheliomas may mimic the appearance of other congenital tumors, such as rhabdomyosarcoma or neuroblastoma. It may also cause Kasabach-Merritt syndrome leading to platelet trapping and localized disseminated intravascular coagulation.
Dr. Listernick: What's the difference between hemangioma and hemangioendothelioma?
Dr. Mancini: They are proliferative neoplasms. Hemangiomas stain GLUT1 positive. They are vascular neoplasms composed of endothelial cells and well-formed vascular channels that have a typical life cycle, with appearance in the fi rst couple weeks of life, rapid growth for the fi rst 6 months of life and, ultimately, spontaneous involution. They never become malignant. We suspect they're derived from embolized placental cells. Hemangioendotheliomas are proliferative neoplasms that only rarely involute spontaneously but are not considered malignant. Histologic examination may be necessary to distinguish between these two. Dr. Listernick: Can hemangioendotheliomas be surgically removed?
Ricardo Superina, MD, pediatric surgeon: There's a very limited surgical role. Typically the tumor is scattered throughout the liver, which is why I didn't believe that is what this baby had. Occasionally, we can decrease the amount of blood fl ow going to the tumor and partially ameliorate the congestive heart failure.
Dr. Listernick: Is there a role for chemotherapy?
Jason Fangusaro, MD, pediatric hematologist: Although there are no large prospective controlled studies demonstrating effi cacy, there are a variety of therapies that have been used in proliferating hemangiomas and hemangioendotheliomas. Interferon has been used in the past, but there's a signifi cant risk of central nervous system involvement and the development of spastic diplegia. Vincristine and high-dose corticosteroids have been used with some success.
Dr. Mancini: An exciting new therapy for hemangiomas has recently been described. French physicians noted that, in three babies who were being treated with propanolol for cardiac indications, their cutaneous hemangiomas involuted rapidly. This observation was confirmed in eight subsequent infants and reported in The New England Journal of Medicine. There's currently a large multicenter international protocol designed to prove this conclusively. We have even successfully treated one patient with hepatic hemanfi rm rounds There are three possible patterns of liver hemangiomas.
giomas with propanolol who had congestive heart failure. Dr. Listernick: Do we understand the proposed mechanism of action?
Dr. Mancini: Although it's not as yet understood, alternate theories include that propanolol either has antiangiogenic activity or induces apoptosis in the endothelial cells of the hemangiomas.
Dr. Listernick: Can we control this child's heart failure medically?
Dr. Franklin: Short of removing the offending lesion, it's very diffi cult. We can make sure that the child's oxygen carrying capacity is optimal by correcting anemia. Normally, we would attempt to lower systemic vascular resistance with milrinone to decrease the strain on the heart; however, in this case, the resistance is already too low because of the vascular tumor. Inotropes may provide some benefi t. We tried dobutamine, which helped minimally at best. Dr. Listernick: Is there a role for embolization of large blood vessels by interventional radiology? Dr. Superina: I initially thought that this was an AVM and that embolization might be helpful. The computerized tomography (CT) scan showed multiple feeder vessels going to the lesion. However, there have been times when we've embolized vessels only to fi nd that blood fl ow to the tumor increases through other collaterals.
Dr. Listernick: Moving forward, during the fi rst week of life as the best approach to this child's liver mass was being debated, ultrasonography of his head revealed severe hydrocephalus and multiple hypoechoic intracranial masses.
In addition, a soft tissue mass was noted on the right side of the baby's mandible. Magnetic resonance imaging (MRI) confi rmed the presence of multiple solid intracranial masses, the mandibular mass and, fi nally, the iris lesions that had grown during the fi rst week of life. I hadn't said much about these lesions, but they were tan and looked like bits of "gum" on the irides. I think that it's fair to say that the radiologists had a diffi cult time constructing a differential diagnosis. Interventional radiology performed a needle biopsy of the mandibular mass.
Pauline Chou, MD, pediatric pathologist: The cells are quite large and look epithelioid with abundant cytoplasm and prominent nucleoli, rather than the endothelial cells that we would see in a vascular tumor. The cells are arranged in two layer cords that resemble fetal hepatocytes. These are separated by canaliculi with extramedullary hematopoiesis, a common fi nding in fetal liver. Admixed are some embryonal component as well. Overall, the tumor is clearly metastatic hepatoblastoma.
Dr. Listernick: How common are hepatic tumors in children? Dr. Chou: Primary hepatic tumors comprise 1% of primary malignancies in children. Hepatoblastoma is the most common malignant liver tumor of infants. In one study, pediatric liver tumors in order of decreasing frequency were the group of vascular tumors we've previously mentioned, mesenchymal hamartomas, and fi nally hepatoblastoma. Hepatoblastoma typically metastasizes to the lungs, but involvement of the bones, brain, and eyes has also been reported 
